Description
O3 Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: O3 Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis
€2.42
